1. Home
  2. ELVA vs LCTX Comparison

ELVA vs LCTX Comparison

Compare ELVA & LCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Electrovaya Inc.

ELVA

Electrovaya Inc.

HOLD

Current Price

$6.90

Market Cap

329.2M

Sector

N/A

ML Signal

HOLD

Logo Lineage Cell Therapeutics Inc.

LCTX

Lineage Cell Therapeutics Inc.

N/A

Current Price

$1.08

Market Cap

301.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ELVA
LCTX
Founded
1996
1990
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
329.2M
301.7M
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
ELVA
LCTX
Price
$6.90
$1.08
Analyst Decision
Buy
Strong Buy
Analyst Count
1
4
Target Price
$14.00
$6.25
AVG Volume (30 Days)
599.1K
804.3K
Earning Date
05-13-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$14,556,000.00
Revenue This Year
$34.68
$109.40
Revenue Next Year
$51.48
N/A
P/E Ratio
$78.51
N/A
Revenue Growth
N/A
53.24
52 Week Low
$4.10
$1.00
52 Week High
$12.78
$2.09

Technical Indicators

Market Signals
Indicator
ELVA
LCTX
Relative Strength Index (RSI) 40.68 46.46
Support Level $6.23 $1.02
Resistance Level $8.98 $1.18
Average True Range (ATR) 0.35 0.05
MACD 0.02 0.00
Stochastic Oscillator 29.70 34.48

Price Performance

Historical Comparison
ELVA
LCTX

About ELVA Electrovaya Inc.

Electrovaya Inc is a technology-focused lithium-ion battery company engaged in designing, developing and manufacturing battery cells, modules and systems based on its proprietary Infinity Battery Technology, which provides high safety performance, long cycle life and durability. The Company supplies low-voltage and high-voltage battery systems for industrial and transportation markets, including material-handling equipment, robotic vehicles, electric buses and trucks, and energy-storage installations, and its products are suitable for mission-critical applications. it maintains an expanding intellectual-property portfolio, develops next-generation solid-state and hybrid solid-state battery technologies, and sells its products through OEM relationships, dealer networks and direct sales.

About LCTX Lineage Cell Therapeutics Inc.

Lineage Cell Therapeutics Inc is a clinical-stage biotechnology company focused on the development and commercialization of novel therapies for the treatment of degenerative diseases. The company's pipeline currently includes: OpRegen, OPC1, ReSonance, ILT1, RND1, PNC1, and LCT-CON. Its programs are based on its proprietary, in-house, cell-based manufacturing platform, which it call AlloSCOPE (Allogeneic, Scalable, Consistent, Off-the-shelf, Pluripotent Cell Engineering), and supported by its associated development, formulation, manufacturing, and delivery capabilities. The AlloSCOPE platform is a proprietary differentiation and production modality from which, a single, well-characterized pluripotent cell line can create a stable current Good Manufacturing Practice, master cell bank.

Share on Social Networks: